Strand Life Sciences

Strand Enters the Healthcare Field with Software Products and Services that Integrate Advanced Visualization, System Modeling, and Scientific Insights to Enable Biological and Health Science Research. Currently, over 2,000 research laboratories globally (accounting for approximately 30% of the global market share) and 100 hospitals have adopted Strand's genomics solutions. These include leading clinical research, pharmaceutical, and biotechnology organizations. Strand boasts a highly skilled, interdisciplinary team of more than 200 computer and life scientists and has established three clinical and translational research laboratories in Bangalore, equipped with advanced next-generation sequencing (NGS) technology. Strand is a portfolio company, with Biomark Capital Partners being a global health and life sciences fund headquartered in San Francisco. By utilizing DNA sequence-based diagnostics and clinical genomic data interpretation, supported by robust computational, scientific, and medical expertise, Strand is bringing personalized medicine to the world.